1.
Product Overview
2.
Research Methodology
3. Executive Summary
4.
Voice of Customer
5.
Global Intravenous Iron Drugs Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value & Volume
5.2.
Market Share & Forecast
5.2.1. By Application (Intestinal
malabsorption syndromes, Inflammatory diseases, Gastrectomy/bariatric surgery, Anemia,
Osier-Weber-Rendu disease, Angiodysplasia, Pregnancy, Others)
5.2.2. By Product (Iron
dextran, Ferric gluconate, Iron sucrose, Ferric carboxymaltos, Iron
isomaltoside 1000, Ferumoxytol)
5.2.3. By End-User (Hospitals,
Clinics, Others)
5.2.4. By Company (2021)
5.2.5. By Region
5.3. Market Attractiveness Index
6.
Asia-Pacific Intravenous Iron Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value & Volume
6.2.
Market Share & Forecast
6.2.1. By Application
6.2.2. By Product
6.2.3. By End-User
6.2.4.
By Country
6.3.
Market Attractiveness Index
6.4.
Asia-Pacific: Country Analysis
6.4.1.
China Intravenous Iron Drugs Market Outlook
6.4.1.1.
Market Size & Forecast
6.4.1.1.1.
By Value
6.4.1.2.
Market Share & Forecast
6.4.1.2.1.
By Application
6.4.1.2.2.
By Product
6.4.1.2.3.
By End-User
6.4.2.
India Intravenous Iron Drugs Market Outlook
6.4.2.1.
Market Size & Forecast
6.4.2.1.1.
By Value
6.4.2.2.
Market Share & Forecast
6.4.2.2.1.
By Application
6.4.2.2.2.
By Product
6.4.2.2.3.
By End-User
6.4.3.
Japan Intravenous Iron Drugs Market Outlook
6.4.3.1.
Market Size & Forecast
6.4.3.1.1.
By Value
6.4.3.2.
Market Share & Forecast
6.4.3.2.1.
By Application
6.4.3.2.2.
By Product
6.4.3.2.3.
By End-User
6.4.4.
South Korea Intravenous Iron Drugs Market Outlook
6.4.4.1.
Market Size & Forecast
6.4.4.1.1.
By Value
6.4.4.2.
Market Share & Forecast
6.4.4.2.1.
By Application
6.4.4.2.2.
By Product
6.4.4.2.3.
By End-User
6.4.5.
Singapore Intravenous Iron Drugs Market Outlook
6.4.5.1.
Market Size & Forecast
6.4.5.1.1.
By Value
6.4.5.2.
Market Share & Forecast
6.4.5.2.1.
By Application
6.4.5.2.2.
By Product
6.4.5.2.3.
By End-User
6.4.6.
Australia Intravenous Iron Drugs Market Outlook
6.4.6.1.
Market Size & Forecast
6.4.6.1.1.
By Value
6.4.6.2.
Market Share & Forecast
6.4.6.2.1.
By Application
6.4.6.2.2.
By Product
6.4.6.2.3.
By End-User
7.
Europe Intravenous Iron Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value & Volume
7.2.
Market Share & Forecast
7.2.1. By Application
7.2.2. By Product
7.2.3. By End-User
7.2.4.
By Country
7.3.
Market Attractiveness Index
7.4.
Europe: Country Analysis
7.4.1.
France Intravenous Iron Drugs Market Outlook
7.4.1.1.
Market Size & Forecast
7.4.1.1.1.
By Value
7.4.1.2.
Market Share & Forecast
7.4.1.2.1.
By Application
7.4.1.2.2.
By Product
7.4.1.2.3.
By End-User
7.4.2.
Germany Intravenous Iron Drugs Market Outlook
7.4.2.1.
Market Size & Forecast
7.4.2.1.1.
By Value
7.4.2.2.
Market Share & Forecast
7.4.2.2.1.
By Application
7.4.2.2.2.
By Product
7.4.2.2.3.
By End-User
7.4.3.
United Kingdom Intravenous Iron Drugs Market Outlook
7.4.3.1.
Market Size & Forecast
7.4.3.1.1.
By Value
7.4.3.2.
Market Share & Forecast
7.4.3.2.1.
By Application
7.4.3.2.2.
By Product
7.4.3.2.3.
By End-User
7.4.4.
Italy Intravenous Iron Drugs Market Outlook
7.4.4.1.
Market Size & Forecast
7.4.4.1.1.
By Value
7.4.4.2.
Market Share & Forecast
7.4.4.2.1.
By Application
7.4.4.2.2.
By Product
7.4.4.2.3.
By End-User
8.
North America Intravenous Iron Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value & Volume
8.2.
Market Share & Forecast
8.2.1. By Application
8.2.2. By Product
8.2.3. By End-User
8.2.4.
By Country
8.3.
Market Attractiveness Index
8.4.
North America: Country Analysis
8.4.1.
United States Intravenous Iron Drugs Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Application
8.4.1.2.2.
By Product
8.4.1.2.3.
By End-User
8.4.2.
Mexico Intravenous Iron Drugs Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Application
8.4.2.2.2.
By Product
8.4.2.2.3.
By End-User
8.4.3.
Canada Intravenous Iron Drugs Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Application
8.4.3.2.2.
By Product
8.4.3.2.3.
By End-User
9.
South America Intravenous Iron Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value & Volume
9.2.
Market Share & Forecast
9.2.1. By Application
9.2.2. By Product
9.2.3. By End-User
9.2.4.
By Country
9.3.
Market Attractiveness Index
9.4.
South America: Country Analysis
9.4.1.
Brazil Intravenous Iron Drugs Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Application
9.4.1.2.2.
By Product
9.4.1.2.3.
By End-User
9.4.2.
Argentina Intravenous Iron Drugs Market Outlook
9.4.2.1.
Market Size & Forecast
9.4.2.1.1.
By Value
9.4.2.2.
Market Share & Forecast
9.4.2.2.1.
By Application
9.4.2.2.2.
By Product
9.4.2.2.3.
By End-User
9.4.3.
Colombia Intravenous Iron Drugs Market Outlook
9.4.3.1.
Market Size & Forecast
9.4.3.1.1.
By Value
9.4.3.2.
Market Share & Forecast
9.4.3.2.1.
By Application
9.4.3.2.2.
By Product
9.4.3.2.3.
By End-User
10.
Middle East and Africa Intravenous Iron Drugs
Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value & Volume
10.2.
Market Share & Forecast
10.2.1. By Application
10.2.2. By Product
10.2.3. By End-User
10.2.4.
By Country
10.3.
Market Attractiveness Index
10.4.
MEA: Country Analysis
10.4.1.
South Africa Intravenous Iron Drugs Market Outlook
10.4.1.1.
Market Size & Forecast
10.4.1.1.1.
By Value
10.4.1.2.
Market Share & Forecast
10.4.1.2.1.
By Application
10.4.1.2.2.
By Product
10.4.1.2.3.
By End-User
10.4.2.
Saudi Arabia Intravenous Iron Drugs Market Outlook
10.4.2.1.
Market Size & Forecast
10.4.2.1.1.
By Value
10.4.2.2.
Market Share & Forecast
10.4.2.2.1.
By Application
10.4.2.2.2.
By Product
10.4.2.2.3.
By End-User
10.4.3.
UAE Intravenous Iron Drugs Market Outlook
10.4.3.1.
Market Size & Forecast
10.4.3.1.1.
By Value
10.4.3.2.
Market Share & Forecast
10.4.3.2.1.
By Application
10.4.3.2.2.
By Product
10.4.3.2.3.
By End-User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
13.
Competitive Landscape
13.1.
Competition Outlook
13.2.
Players Profiled (Leading Companies)
13.2.1.
AMAG pharmaceuticals, Inc.
13.2.2.
Vifor Pharma Group
13.2.3.
Daiichi Sankyo Company, Limited
13.2.4.
Sanofi SA
13.2.5.
Rockwell Medical Inc.
13.2.6.
Allergan PLC
13.2.7.
Pfizer Inc
13.2.8.
Nippon Shinyaku Co.
13.2.9.
Novartis International AG
13.2.10.
Takeda Pharmaceutical Company Limited
13.2.11.
Bausch Health Companies Inc.
13.2.12.
Shield Therapeutics PLC
13.2.13.
Merck & Co., Inc.
13.2.14.
Biocon Limited
14. Strategic Recommendations
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com